NEW ENGLAND SECURITIES CORP /MA/ - NPS PHARMACEUTICALS INC ownership

NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 212 filers reported holding NPS PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 1.37 and the average weighting 0.2%.

Quarter-by-quarter ownership
NEW ENGLAND SECURITIES CORP /MA/ ownership history of NPS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$222,000
+42.3%
6,195
+3.3%
0.08%
+41.8%
Q3 2014$156,000
-15.7%
5,995
+7.1%
0.06%
-14.1%
Q2 2014$185,000
-40.7%
5,595
-46.3%
0.06%
+6.7%
Q1 2014$312,000
+115.2%
10,410
+118.5%
0.06%0.0%
Q4 2013$145,000
+27.2%
4,765
+32.9%
0.06%
+3.4%
Q3 2013$114,000
+100.0%
3,585
-5.3%
0.06%
+52.6%
Q2 2013$57,0003,7850.04%
Other shareholders

There were no reported owners of NPS PHARMACEUTICALS INC in Q1 2014.

NameSharesValueWeighting ↓
View complete list of NPS PHARMACEUTICALS INC shareholders